|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| C07H 19/00 | (2006.01) | ||
| C07H 19/04 | (2006.01) | ||
| C07H 21/00 | (2006.01) | ||
| A61P 31/20 | (2006.01) |
| (11) | Number of the document | 3090748 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16158945.2 |
| Date of filing the European patent application | 2006-12-13 | |
| (97) | Date of publication of the European application | 2016-11-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (30) | Number | Date | Country code |
| 750036 P | 2005-12-13 | US | |
| 800294 P | 2006-05-15 | US | |
| 637520 | 2006-12-12 | US |
| (72) |
IYER, Radhakrishnan, P., US
PADMANABHAN, Seetharamaiyer, US
|
| (73) |
Spring Bank Pharmaceuticals, Inc.,
35 Parkwood Drive Suite 210, Hopkinton, MA 01748,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos, apimančios nukleotido ir oligonukleotido provaistus |
| COMPOSITIONS COMPRISING NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS |
| Payment date | Validity (years) | Amount | |
| 2019-12-03 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-12-13 |